eBook: Explore pathways like a pro
Scientists studying particular disease states often search cellular signaling pathways to gain insight into DNA, RNA, and protein function.
List view / Grid view
Scientists studying particular disease states often search cellular signaling pathways to gain insight into DNA, RNA, and protein function.
GeneArt High-Q Strings DNA Fragments versus other suppliers’ products.
Antisense oligonucleotides are an emerging therapeutic option for treating diseases with known genetic origin.
Innovations in synthesis technology and gene synthesis have become a powerful and valuable means of obtaining genetic material.
This In-Depth Focus features articles highlighting the importance of effective data management strategies as well as the recent trends in upstream bioprocessing.
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
The process of Salmonella typhi to damage DNA has been revealed by researchers at the University of Sheffield which could inform treatments.
The novel method for imaging molecules in cells and tissue samples, called DNA microscopy, could improve knowledge of disease development.
Researchers have mapped a previously uncharted region of the human genome which could lead to tests for certain conditions in the future.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
The so-called 'longevity gene' has been included in animal models, in which it stopped atherosclerosis.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.